H ashimoto' s encephalopathy (HE) is a rare neuroendocrine disorder characterised by high titres of anti-thyroid antibodies (thyroid peroxidase antibody, TPoA), manifesting with seizures, tremor, myoclonus, ataxia, psychosis, or strokelike episodes, with a relapsing/remitting or progressive course. 1 Although steroid is the standard treatment option, various immunosuppressive therapies including azathioprine and cyclophosphamide have been tried. A successful outcome with plasmapheresis has been reported in only one case previously. 2 A 51-year-old female patient with confirmed diagnosis of HE was referred to the intensive care unit (ICU) following hypoxic respiratory peri-arrest from a failed tracheal extubation following general anaesthesia (GA) for computed tomography pulmonary angiogram (CTPA) to exclude pulmonary emboli. Previously, the patient had responded well to steroids during relapses, however the illness subsequently had become resistant to this treatment, as documented in a previous report. 1 The patient then started receiving IV immunoglobulins (IVIgs) for future relapses with good response.
During this relapse, despite being on IVIgs, there was minimal improvement in symptoms. IVIgs had to be stopped after four days because of neutropenia. A GA was requested for CTPA in view of the patient' s agitation and tachypnoea. Tracheal intubation and transfer to the radiology department was uneventful. An appropriate neuromuscular blockade reversal agent had been given prior to tracheal extubation. Clinically, the patient had made a full recovery from neuromuscular blockade. However 20 minutes later, the patient became hypoxic and suffered a respiratory peri-arrest.
The patient was re-intubated immediately. Repeat CTPA and CT head and abdomen were performed both of which were reported normal. There was no evidence of other factors that can prolong neuromuscular blockade, for example hypothermia, other muscular disorders, electrolyte imbalance or sepsis.
The patient was then transferred to ICU for further management. The patient required minimal mechanical ventilation support and gas exchange was normal. It was noted that the patient continued to be agitated and uncooperative but did not have clinical evidence of fitting. In addition, the patient became hypothermic and polyuric. A decision to start plasmapheresis was made after a multidisciplinary team meeting. The patient self-extubated successfully a day after plasmapheresis was started. The patient' s Glasgow Coma Scale (GCS) was 15/15 and she exhibited minimal weakness on the right side. The patient was discharged from ICU and subsequently went home one week later. Outpatient neurology follow up confirms good recovery from ICU admission with no complications.
Respiratory failure, bulbar involvement or autonomic instability as a feature of HE has not been documented in the literature before. In previous reported cases, patients needed ventilatory support for status epilepticus or low GCS at their initial presentation. The normal imaging of chest and head excluded other causes of this patient' s clinical deterioration.
There are no reports of outcomes after GA in patients with this unusual condition. We believe that the patient' s respiratory failure after the GA was not related to infection, retained neuromuscular blockade or metabolic disturbance, but W e have all witnessed the shocking collapse of the young footballer Fabrice Muamba with the subsequent, thus far successful, resuscitation and his continued improvement. The input of our colleagues from cardiology has, as is usually the case, been widely publicised with the 'running onto the pitch' of a consultant cardiologist. What is not as well published is the expert effective input from the intensivists. Why is it that intensive care, and the doctors, nurses and other staff that work there, are not given the recognition that they are receiving in Europe? The classic example is the case of Eric Abidal, the Barcelona football defender who following his liver transplantation has become an ambassador for the ESICM (European Society of Intensive Care Medicine).
